Oncology

Oncology
Name	Oncology
Field	cancer research institutions, World Health Organization programs
Specialist	Oncologists, Radiation oncologists, Surgical oncologists, Medical oncologists

Oncology Oncology is the medical specialty concerned with the study, diagnosis, treatment, and prevention of cancer. It integrates clinical practice, laboratory research, and public health efforts centered at institutions such as the National Cancer Institute, European Society for Medical Oncology, and regional centers like MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Oncology draws on advances from disciplines represented by organizations like the American Society of Clinical Oncology and international collaborations such as the International Agency for Research on Cancer.

Overview

Oncology encompasses subspecialties including medical oncology, radiation oncology, and surgical oncology, with ancillary roles filled by pathologists, radiologists, hematologists, and multidisciplinary tumor boards at centers like Johns Hopkins Hospital and The Royal Marsden. Training pathways often proceed through programs accredited by national bodies such as the American Board of Internal Medicine and the General Medical Council. Clinical practice follows evidence from trials conducted by groups such as the European Organisation for Research and Treatment of Cancer and cooperative networks like the Children's Oncology Group. Health systems implement screening guidelines from agencies like the US Preventive Services Task Force and public campaigns by the World Health Organization.

Causes and Pathophysiology

Cancer arises from genetic and epigenetic alterations that dysregulate cell proliferation, apoptosis, and DNA repair. Key molecular players identified in foundational studies by pioneers at institutions like Cold Spring Harbor Laboratory and The Sanger Institute include oncogenes (e.g., RAS family members), tumor suppressors (e.g., TP53), and pathways elucidated in work linked to National Institutes of Health-funded consortia. Carcinogenesis is influenced by environmental exposures documented in historical investigations such as studies following the Chernobyl disaster and occupational cohorts like those studied after incidents at Three Mile Island. Viral oncogenesis has been characterized in pathogens including Human papillomavirus, implicated in cervical cancer research led by groups at Karolinska Institutet, and Epstein–Barr virus in nasopharyngeal carcinoma studies centered in collaborations involving Peking University. Inherited cancer predisposition syndromes (e.g., BRCA1/BRCA2 mutations) were defined through efforts at centers such as University of Pennsylvania and influenced genetic counseling programs at institutions like St. Jude Children's Research Hospital.

Diagnosis and Staging

Diagnosis integrates clinical examination, imaging, tissue biopsy, and molecular assays. Imaging modalities validated in trials by radiology departments at places like Massachusetts General Hospital include computed tomography and magnetic resonance imaging; nuclear medicine techniques such as positron emission tomography were refined at institutions like Mayo Clinic. Pathology practices follow classifications from organizations like the World Health Organization and staging systems promulgated by the American Joint Committee on Cancer and the Union for International Cancer Control. Molecular diagnostics developed in laboratories at Broad Institute and European Molecular Biology Laboratory provide genomic profiling, while biomarker validation has been advanced by projects such as The Cancer Genome Atlas and consortia involving Wellcome Trust funding. Staging informs prognosis and was standardized through historical trials run by groups including the National Surgical Adjuvant Breast and Bowel Project.

Treatment Modalities

Therapeutic strategies combine surgery, radiation, systemic therapy, and supportive care. Landmark surgical innovations emerged from surgeons affiliated with Guy's Hospital and Royal Marsden Hospital, while radiotherapy techniques were pioneered at centers like Institut Gustave Roussy and Memorial Sloan Kettering Cancer Center. Systemic therapies include cytotoxic chemotherapy developed in programs at Dana–Farber Cancer Institute and targeted agents originating from collaborations between academia and industry exemplified by partnerships with GlaxoSmithKline and Novartis. Immunotherapy advances, including checkpoint inhibitors inspired by work at Yale University and adoptive cell therapies refined at Fred Hutchinson Cancer Center, have transformed management of several tumors. Multimodal treatment protocols are tested in randomized trials coordinated by networks such as the National Cancer Research Institute and implemented in guidelines by professional societies like European Society for Medical Oncology.

Epidemiology and Prevention

Epidemiologic patterns are tracked by surveillance systems at agencies like the Centers for Disease Control and Prevention and analyzed in reports by the International Agency for Research on Cancer. Incidence and mortality vary by region, with disparities studied in cohorts from populations served by Harvard T.H. Chan School of Public Health and public health programs run by UNICEF in resource-limited settings. Primary prevention strategies include vaccination campaigns (e.g., against Human papillomavirus led by ministries of health and organizations such as Gavi), tobacco control policies influenced by frameworks from the World Health Organization, and occupational safety laws shaped after investigations by bodies like the Occupational Safety and Health Administration. Screening programs for breast, cervical, and colorectal cancer follow evidence from trials run by groups like the UK National Screening Committee and recommendations from the US Preventive Services Task Force.

Research and Emerging Therapies

Research spans basic science at laboratories like Salk Institute and translational studies in academic medical centers such as UCSF Medical Center. Genomic and proteomic initiatives including The Cancer Genome Atlas and projects funded by the Wellcome Trust drive biomarker discovery. Precision medicine trials coordinated by entities like the National Cancer Institute and industry partnerships with companies such as Roche and Pfizer pursue targeted agents and combination regimens. Emerging modalities include CAR T-cell therapy advanced at University of Pennsylvania, oncolytic virotherapy investigated at Roswell Park Comprehensive Cancer Center, and novel delivery systems developed in collaborations involving MIT and Stanford University. International consortia including the Global Alliance for Genomics and Health aim to harmonize data sharing and accelerate translation from bench to bedside.

Category:Medical specialties